Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
2002 | 2 |
2004 | 1 |
2010 | 1 |
2013 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
Clin Infect Dis. 2010 Feb 15;50(4):605-12. doi: 10.1086/650002.
Clin Infect Dis. 2010.
PMID: 20085491
Free PMC article.
Clinical Trial.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams.
Eron JJ, et al.
Lancet Infect Dis. 2013 Jul;13(7):587-96. doi: 10.1016/S1473-3099(13)70093-8. Epub 2013 May 7.
Lancet Infect Dis. 2013.
PMID: 23664333
Free PMC article.
Clinical Trial.
Item in Clipboard
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
Bartlett JA, Benoit SL, Johnson VA, Quinn JB, Sepulveda GE, Ehmann WC, Tsoukas C, Fallon MA, Self PL, Rubin M.
Bartlett JA, et al. Among authors: sepulveda ge.
Ann Intern Med. 1996 Aug 1;125(3):161-72. doi: 10.7326/0003-4819-125-3-199608010-00001.
Ann Intern Med. 1996.
PMID: 8686973
Clinical Trial.
Item in Clipboard
The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.
Rodriguez-French A, Boghossian J, Gray GE, Nadler JP, Quinones AR, Sepulveda GE, Millard JM, Wannamaker PG.
Rodriguez-French A, et al. Among authors: sepulveda ge.
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):22-32. doi: 10.1097/00126334-200401010-00003.
J Acquir Immune Defic Syndr. 2004.
PMID: 14707788
Clinical Trial.
Item in Clipboard
Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients.
Sension MG, Bellos NC, Johnson J, Sepulveda GE, DeJesus E, Santana JL, Ames MH, Goodwin SD.
Sension MG, et al. Among authors: sepulveda ge.
HIV Clin Trials. 2002 Sep-Oct;3(5):361-70. doi: 10.1310/7c8q-qujl-ek1c-n238.
HIV Clin Trials. 2002.
PMID: 12407485
Clinical Trial.
Item in Clipboard
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
Kessler HA, Johnson J, Follansbee S, Sension MG, Mildvan D, Sepulveda GE, Bellos NC, Hetherington SV.
Kessler HA, et al. Among authors: sepulveda ge.
Clin Infect Dis. 2002 Feb 15;34(4):535-42. doi: 10.1086/338638. Epub 2002 Jan 4.
Clin Infect Dis. 2002.
PMID: 11797183
Clinical Trial.
Item in Clipboard
Cite
Cite